Literature DB >> 20976866

Rheumatoid arthritis: monitoring serum concentration of infliximab might improve RA disease control.

Sarah Price.   

Abstract

Entities:  

Year:  2010        PMID： 20976866     DOI： 10.1038/nrrheum.2009.271

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis.

Authors:  Denis Mulleman; Jean-Camille Méric; Gilles Paintaud; Emilie Ducourau; Charlotte Magdelaine-Beuzelin; Jean-Pierre Valat; Philippe Goupille
Journal:  Arthritis Res Ther       Date:  2009-11-25       Impact factor: 5.156
  1 in total
  2 in total

1.  Plasma infliximab monitoring contributes to optimize Takayasu arteritis treatment: a case report.

Authors:  Sho Masui; Atsushi Yonezawa; Kazushi Izawa; Makoto Hayakari; Kayoko Asakura; Risa Taniguchi; Masahiko Isa; Hirofumi Shibata; Takahiro Yasumi; Ryuta Nishikomori; Junko Takita; Kazuo Matsubara
Journal:  J Pharm Health Care Sci       Date:  2019-05-02

2.  Verification between Original and Biosimilar Therapeutic Antibody Infliximab Using nSMOL Coupled LC-MS Bioanalysis in Human Serum.

Authors:  Noriko Iwamoto; Kotoko Yokoyama; Megumi Takanashi; Atsushi Yonezawa; Kazuo Matsubara; Takashi Shimada
Journal:  Curr Pharm Biotechnol       Date:  2018       Impact factor: 2.837
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.